The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations of inflated drug prices and rebate-driven formulary exclusions. The agreement bans the PBM ...
Jefferson County’s long-running opioid fight with pharmacy benefit managers Express Scripts and Optum Rx now has a firm trial ...
Rapidly growing pharmaceutical services platform expands life sciences consulting capabilities with key leadership additions NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Petauri, a purpose-built ...
Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced IMULDOSA® (ustekinumab-srlf) is now covered by ...
Decision Expands Coverage to National Preferred Formulary Commercially Insured LivesMONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a ...
Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...
On February 4, 2026, the Federal Trade Commission (FTC) proposed to settle its enforcement action against leading pharmacy benefit manager (PBM) Express Scripts, going beyond the insulin products that ...
The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...
On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results